KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a Once-Daily pill be enough for kidney transplant patients?
Disease control TerminatedThis study tested whether a once-daily extended-release form of tacrolimus (Envarsus XR) combined with azathioprine works as well as the standard twice-daily tacrolimus with mycophenolate for preventing kidney transplant rejection. The trial planned to enroll 20 kidney transplant…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New hope for kidney transplant patients: safer rejection prevention?
Disease control TerminatedThis study tested a new drug called TCD601 (siplizumab) in 33 kidney transplant patients to see if it could safely prevent organ rejection. The drug was compared to a standard treatment (ATG). The trial was stopped early, so we have limited information, but the goal was to find a…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
Kidney transplant drug switch aims to reduce side effects
Disease control TerminatedThis study looked at switching kidney transplant patients from the drug tacrolimus to sirolimus (both paired with mycophenolate mofetil) to see if it lowers the risk of kidney damage, new diabetes, and cancer. The trial included 65 stable transplant recipients between 1 and 3 yea…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
Kidney transplant breakthrough? drug combo aims to reduce lifelong pills
Disease control TerminatedThis study tested a drug called siplizumab combined with donor bone marrow cells to help kidney transplant patients potentially stop taking anti-rejection drugs long-term. Only 4 people took part before the study was ended early. The goal was to find the best dose to safely allow…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New ultrasound technique aims to catch kidney transplant trouble sooner
Diagnosis TerminatedThis study tested a special ultrasound that uses a contrast dye to get clearer images of a new kidney after transplant. The goal was to see if this method could help doctors find early signs of problems like rejection or slow function. The study was small (20 people) and was stop…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1 • Sponsor: University of Utah • Aim: Diagnosis
Last updated Jun 08, 2026 13:10 UTC